Zentrum für Rhinologie und Allergologie - GEKAmbH
- Address
- Berta-Cramer-Ring 30, 65205 Wiesbaden, Germany
Zentrum für Rhinologie und Allergologie - GEKAmbH
The Zentrum für Rhinologie und Allergologie - GEKAmbH is a specialized research center dedicated to advancing the understanding and treatment of rhinological and allergological conditions. The center focuses on innovative therapeutic approaches for chronic sinonasal disorders, conducting rigorous clinical investigations to evaluate emerging treatment modalities that address unmet medical needs in patients with chronic upper airway diseases.
- Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)
- Novel pharmacological interventions for nasal symptom management
- Efficacy and safety evaluation of targeted therapies
The center's research portfolio includes participation in pivotal clinical trials investigating brensocatib, a promising therapeutic agent for chronic rhinosinusitis without nasal polyps. Through systematic assessment of treatment efficacy in improving nasal symptoms, the center contributes valuable clinical data that supports the development of next-generation therapies for patients suffering from chronic inflammatory conditions of the upper respiratory tract.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Zentrum für Rhinologie und Allergologie - GEKAmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps – The BiRCh Study | Insmed Inc. | Phase II | Not Recruiting | May 2024 | Oct 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BRENSOCATIB | 1 | Unknown | 2024-05-23 | 2024-05-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.